Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022

Business Wire October 17, 2022

Bio-Rad Acquires Curiosity Diagnostics

Business Wire August 3, 2022

Bio-Rad Reports Second-Quarter 2022 Financial Results

Business Wire July 28, 2022

Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022

Business Wire July 18, 2022

Bio-Rad Publishes Corporate Sustainability Report

Business Wire June 27, 2022

Bio-Rad Reports First-Quarter 2022 Financial Results

Business Wire April 28, 2022

Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022

Business Wire April 18, 2022

Bio-Rad Announces Closing of $1.2 Billion Aggregate Senior Notes Offering

Business Wire March 2, 2022

Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day

Business Wire February 25, 2022

Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results

Business Wire February 10, 2022

Bio-Rad to Host Investor Day on February 25

Business Wire February 2, 2022

Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022

Business Wire January 25, 2022

Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11

Business Wire January 5, 2022

Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President

Business Wire December 16, 2021

Bio-Rad Reports Third-Quarter 2021 Financial Results

Business Wire October 28, 2021

Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021

Business Wire October 15, 2021

Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference

Business Wire August 31, 2021

Bio-Rad Reports Second-Quarter 2021 Financial Results

Business Wire July 29, 2021

Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations

Business Wire July 27, 2021

10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad

GlobeNewswire July 27, 2021